Author:
Stevens Henry,de la Paz Max,Cooper Blake,Bhattacharya Rajib
Reference13 articles.
1. A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes (FOCUS). ClinicalTrials.gov Identifier: NCT03811561.
2. 2019 worsening of diabetic retinopathy with rapid improvement in systemic glucose control: a review;Bain;Diabetes Obes. Metab.,2019
3. Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12;Early Treatment Diabetic Retinopathy Study Research Group;Ophthalmology,1991
4. Topical administration of GLP-1 receptor agonists prevents retinal neurodegeneration in experimental diabetes;Hernández;Diabetes,2016
5. Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes;Husain;N. Engl. J. Med.,2019